Overall Technical outlook

Price Summary

On 2025-10-17, MANKIND's stock opened at 2470.4, reached a peak of 2484.8, dropped to 2440.0, and ended 0.25% higher at 2476.6, with a volume of 461336 shares.
The stock reached its highest price of 2998.4 and its lowest price of 2161.7 during the 52-week period.
Analysts expect the price of MANKIND to vary between 2150.0 and 3300.0, with an average expected price near 2794.2942.

Technicals

Support and Resistance: The price of 2476.6 is supported at 2432.4 and capped by resistance at 2564.2. These levels mark key points for Mankind Pharma Limited where the price could find stability, with 2432.4 as a floor and 2564.2 as a ceiling.
MANKIND supportResistance b9b5c1
Support/Resistance for MANKIND


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
MANKIND aroon b9b5c1
Aroon chart for Mankind Pharma Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
MANKIND bbands b9b5c1
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR for MANKIND has recently shifted from a bearish to a bullish direction, indicating a potential trend reversal. When combined with other indicators, this change could signal a strong bullish trend, provided it is supported by a broader market trend. Investors should consider this a positive development, especially if other indicators align with this shift.
MANKIND psar b9b5c1
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
MANKIND stoch b9b5c1
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for MANKIND. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
MANKIND trippleSMA b9b5c1
Tripple SMA chart for Mankind Pharma Limited


To properly assess the technical data of a company, it's important to first look at its fundamentals, such as its earnings, growth potential, and management effectiveness. Equally, understanding the industry trends, competition, and external economic factors that influence the company is vital. This holistic view helps draw meaningful conclusions about the company's technical performance, allowing investors to better gauge its stock price behavior, volatility, and market trends.